Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into nine sections that are reviewed once a year. Each section is assigned one or two Section Editors, leading authorities in the area, who identify the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Richard E. Chaisson
Richard E. Chaisson, MD, is Professor of Medicine, Epidemiology, and International Health and directs the Center for AIDS Research and the Center for Tuberculosis Research at the Johns Hopkins University School of Medicine and Bloomberg School of Public Health in Baltimore, MD, USA. He received his BS and MD degrees from the University of Massachusetts, USA and trained in internal medicine, infectious diseases, and clinical epidemiology at the University of California, San Francisco, USA. He was Director of the Johns Hopkins AIDS Service from 1988–1998 and Medical Director of the Baltimore City Health Department Tuberculosis Control Program from 1991–1999. He founded the Johns Hopkins Center for TB Research in 1998.
His research interests focus on tuberculosis and HIV infection, including epidemiology and natural history, clinical trials, diagnostics and public health interventions. He has been a Principal Investigator in the CDC's TB Trials Consortium since its inception in 1994, leading clinical research sites in Baltimore, Rio de Janeiro, Brazil, and Soweto, South Africa. From 2002–2014 he organized and led the Consortium to Respond Effectively to the AIDS-TB Epidemic (CREATE), a research consortium studying novel public health approaches to reduce the burden of HIV-related TB. From 2011–2017 he was the inaugural chair of the TB Transformative Science Group of the AIDS Clinical Trials Group, leading the development and implementation of this NIH-funded network's TB clinical trials portfolio. In 2012 he reestablished the Johns Hopkins Center for AIDS Research (CFAR), revitalizing a multidisciplinary program to catalyze innovative HIV research, with a special focus on combatting the Baltimore epidemic. He co-chairs the South African Regional Prospective Observational Research on TB (RePORT) Consortium Steering Committee. Dr. Chaisson has published over 490 scientific papers and chapters, and his Handbook of Tuberculosis, co-edited with Jacques Grosset, was published in 2017.
Dr Haileyesus Getahun has been working on antimicrobial resistance in the World Health Organization (WHO) as Coordinator since June 2018. Prior to this appointment, Dr Getahun was a coordinator in the Global TB Programme of WHO, leading WHO's efforts on HIV-associated TB and TB prevention as well as integrated community-based TB activities. In this capacity he served as the lead writer, coordinator or contributor for several TB and HIV policies and guidelines including being the lead writer of the WHO policy on HIV associated TB. He has extensive experience in developing global TB and HIV research priorities and facilitating their implementation through creating, managing and maintaining research networks and platforms. He has played a major role to integrate TB prevention, care and treatment including TB drug resistance into major HIV/AIDS, maternal and child health platforms and among key global stakeholders through advocacy and partnership. He was the recipient of the prestigious Union Scientific Prize in November 2011 for “his contributions to the development of evidence-based TB and HIV policy and practice and for helping in setting the global advocacy agenda for worldwide response among stakeholders”. Dr Getahun has been working with WHO since 2003 in different capacities. Before joining WHO, Dr Getahun worked in several public health areas including HIV/AIDS and other communicable diseases, sexual and reproductive health, nutrition and health systems research in both government and non-government sectors. He was trained as a medical doctor in Ethiopia. He obtained his master's degree in public health from the Free University of Brussels, Belgium and his PhD in public health and epidemiology from the University of Ghent, Belgium and Institute of Tropical Medicine in Antwerp, Belgium. He has contributed nearly 100 peer reviewed publications on different topics and has written several scientific book chapters.